ArticleJournal of the Saudi Heart Association2022
Assessment of Value of Three Dimensional Transesophageal Echocardiography versus Conventional Two Dimensional Transesophageal Echocardiography in Guiding Transcatheter Closure of Atrial Septal Defects and Patent Foramen Ovale.
Article in Journal of the Saudi Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 6 citations in OpenAlex.
- Quantitative assessment and clinical value of right-to-left shunt in patent foramen ovale using three-dimensional transesophageal echocardiography combined with right-heart contrast: a prospective study.Cardiovascular diagnosis and therapy · 2026Article
- 3D-TEE: an essential tool for percutaneous occlusion of atrial septal defects with anomalous band.Journal of cardiothoracic surgery · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the benefit of using three-dimensional transesophageal echocardiography (3DTEE) over conventional two-dimensional transesophageal echocardiography (2DTEE) in evaluation of various morphological features of atrial septal defect (ASD) and patent foramen ovale (PFO) during transcatheter closure. Methods: This is an observational cross sectional study including 115 patients (45 PFO and 70 ASD patients) who underwent 2D/3DTEE guided transcatheter closure from April 2019 to October 2021 in cardiology department, Tanta university hospital. Results: 70 ASD patients were divided into two groups; the pediatric age group (18 patients, mean age 9.05 ± 3.51 years) and the adult group (52 patients, mean age 39.3 ± 10.15 years). ASD morphology was simple in 12.9% and complex in 87.1% of patients, where 3DTEE was superior in the evaluation of posterior, infero posterior rims, fenestrated flimsy rims, aneurysm shape, orientation, and quality of its tissue. Procedural success was defined as complete defect closure with no complications. The procedure was successful in 68 and failed in 2 patients. 45 PFO patients were divided into two groups; the pediatric age group (14 patients, mean age 13.5 ± 3.25 years) and the adult group (31 patients, mean age 35.2 ± 4.5 years). PFO morphology was simple in 22.2% and complex in 77.8% of patients, where 3DTEE was superior in the evaluation of the exact PFO opening from the left atrium, additional fenestrations, aneurysm shape, orientation, and quality of its tissue. The procedure was successful in all patients. Conclusion: 3DTEE guided transcatheter ASD/PFO closure provides an additional value over conventional 2DTEE in assessment of complex ASD/PFO morphology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.